Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01031914 · ClinicalTrials.gov registry record · NA

Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP)

A NA study of Sleep Apnea, Obstructive, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT01031914 is a NA study of Sleep Apnea, Obstructive that has completed, run by Philips Respironics. The registered enrollment target is 36 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01031914, a NA study of Sleep Apnea, Obstructive, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this engineering trial is to develop and validate an algorithm that will deliver Paced Breathing as a ramp feature to obstructive sleep apnea (OSA) subjects using Continuous Positive Airway Pressure (CPAP) therapy. In this trial the investigators will be evaluating the algorithm's ability to correctly distinguish between sleep and wake.

Conditions Studied

Interventions

  • DEVICE Paced Breathing

Study Locations (1)

Massachusetts

  • Philips Respironics - Boston

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2009-10
Est. Completion 2010-09
Phase NA

Sponsor

Philips Respironics

35 total trials

What the Registry Record Tells You About NCT01031914

The ClinicalTrials.gov registry entry for NCT01031914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (86% lower). The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Paced Breathing is the first listed.

NCT01031914 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01031914 about?

NCT01031914 is a clinical study titled "Evaluation of an Algorithm to Detect Sleep and Wake in Continuous Positive Airway Pressure (CPAP)". The purpose of this engineering trial is to develop and validate an algorithm that will deliver Paced Breathing as a ramp feature to obstructive sleep apnea (OSA) subjects using Continuous Positive Airway Pressure (CPAP) therapy. In this trial the investigators will be evaluating the algorithm's abi...

What is the current status of trial NCT01031914?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2009-10. Estimated completion is 2010-09.

What conditions does trial NCT01031914 study?

This clinical trial studies the following conditions: Sleep Apnea, Obstructive.

What interventions are being tested in trial NCT01031914?

The interventions under investigation include: Paced Breathing (DEVICE).

Who is sponsoring clinical trial NCT01031914?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01031914 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Apnea, Obstructive

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.